Tumor-associated trypsin inhibitor and cancer antigen 125 in pelvic masses
- 1 August 1990
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 38 (2) , 170-174
- https://doi.org/10.1016/0090-8258(90)90035-j
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Tumour-associated trypsin inhibitor (TATI) and cancer antigen 125 (CA 125) in mucinous ovarian tumoursBritish Journal of Cancer, 1990
- Alpha1-acid glucoprotein in ovarian cancer with a reference to immunosuppressive acidic protein and cancer antigen 125Cancer, 1989
- The prognostic and therapeutic value of second‐look laparotomy in advanced ovarian cancerBJOG: An International Journal of Obstetrics and Gynaecology, 1988
- The value of preoperative serum CA 125 levels in patients with a pelvic massAmerican Journal of Obstetrics and Gynecology, 1988
- SERUM CA-125 LEVELS IN PREOPERATIVE EVALUATION OF PELVIC MASSES1988
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983
- Immunochemical demonstration of an ovarian cancer‐associated urinary peptideInternational Journal of Cancer, 1982